65 related articles for article (PubMed ID: 22072855)
1. Aberrant methylation of the 3q25 tumor suppressor gene PTX3 in human esophageal squamous cell carcinoma.
Wang JX; He YL; Zhu ST; Yang S; Zhang ST
World J Gastroenterol; 2011 Oct; 17(37):4225-30. PubMed ID: 22072855
[TBL] [Abstract][Full Text] [Related]
2.
Gonzaga IM; Soares Lima SC; Nicolau MC; Nicolau-Neto P; da Costa NM; de Almeida Simão T; Hernandez-Vargas H; Herceg Z; Ribeiro Pinto LF
Clin Epigenetics; 2017; 9():130. PubMed ID: 29296124
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic identification of ADAMTS18 as a novel 16q23.1 tumor suppressor frequently silenced in esophageal, nasopharyngeal and multiple other carcinomas.
Jin H; Wang X; Ying J; Wong AH; Li H; Lee KY; Srivastava G; Chan AT; Yeo W; Ma BB; Putti TC; Lung ML; Shen ZY; Xu LY; Langford C; Tao Q
Oncogene; 2007 Nov; 26(53):7490-8. PubMed ID: 17546048
[TBL] [Abstract][Full Text] [Related]
4. ASO Visual Abstract: Therapeutic Potential of Antibody Targeting Neuronal Pentraxin Receptor in Esophageal Squamous Cell Carcinoma.
Shinozuka T; Kanda M; Sato Y; Shimizu D; Umeda S; Takami H; Hattori N; Hayashi M; Tanaka C; Kodera Y
Ann Surg Oncol; 2024 May; ():. PubMed ID: 38776007
[No Abstract] [Full Text] [Related]
5. Therapeutic Strategy by Neuronal Pentraxin Receptor for Esophageal Squamous Cancer Cells.
Kubo Y; Kajiyama D; Sato K; Fujita T
Ann Surg Oncol; 2024 May; ():. PubMed ID: 38758486
[No Abstract] [Full Text] [Related]
6. PTX3 is an extrinsic oncosuppressor regulating complement-dependent inflammation in cancer.
Bonavita E; Gentile S; Rubino M; Maina V; Papait R; Kunderfranco P; Greco C; Feruglio F; Molgora M; Laface I; Tartari S; Doni A; Pasqualini F; Barbati E; Basso G; Galdiero MR; Nebuloni M; Roncalli M; Colombo P; Laghi L; Lambris JD; Jaillon S; Garlanda C; Mantovani A
Cell; 2015 Feb; 160(4):700-714. PubMed ID: 25679762
[TBL] [Abstract][Full Text] [Related]
7. Role of long pentraxin PTX3 in cancer.
Li D; Hao Z; Nan Y; Chen Y
Clin Exp Med; 2023 Dec; 23(8):4401-4411. PubMed ID: 37438568
[TBL] [Abstract][Full Text] [Related]
8. The crossroad between autoimmune disorder, tissue remodeling and cancer of the thyroid: The long pentraxin 3 (PTX3).
Chiari D; Pirali B; Perano V; Leone R; Mantovani A; Bottazzi B
Front Endocrinol (Lausanne); 2023; 14():1146017. PubMed ID: 37025408
[TBL] [Abstract][Full Text] [Related]
9. Pan-Cancer Analysis of Pentraxin 3: A Potential Biomarker of COVID-19.
Zhou Z; Zhou X; Yang Y; Wang L; Wu Z
Cancers (Basel); 2022 Sep; 14(18):. PubMed ID: 36139597
[TBL] [Abstract][Full Text] [Related]
10. Disruption of the pentraxin 3/CD44 interaction as an efficient therapy for triple-negative breast cancers.
Hsiao YW; Chi JY; Li CF; Chen LY; Chen YT; Liang HY; Lo YC; Hong JY; Chuu CP; Hung LY; Du JY; Chang WC; Wang JM
Clin Transl Med; 2022 Jan; 12(1):e724. PubMed ID: 35090088
[TBL] [Abstract][Full Text] [Related]
11. Determination of Pentraxin-3, Interleukin-8 and Vascular Endothelial Growth Factor Levels in Patients with Gastric Adenocarcinoma.
Yeni M; Korkut E; Aksungur N; Kara S; Askin S; Kartal M
Asian Pac J Cancer Prev; 2021 May; 22(5):1507-1512. PubMed ID: 34048179
[TBL] [Abstract][Full Text] [Related]
12. Do pentraxin 3 and neural pentraxin 2 have different facet function in hepatocellular carcinoma?
Cabiati M; Gaggini M; De Simone P; Del Ry S
Clin Exp Med; 2021 Nov; 21(4):555-562. PubMed ID: 33905035
[TBL] [Abstract][Full Text] [Related]
13. Perspectives on long pentraxin 3 and rheumatoid arthritis: several potential breakthrough points relying on study foundation of the past.
Qiu C; Han Y; Zhang H; Liu T; Hou H; Luo D; Yu M; Bian K; Zhao Y; Xiao X
Int J Med Sci; 2021; 18(8):1886-1898. PubMed ID: 33746606
[TBL] [Abstract][Full Text] [Related]
14. Aberrant DNA Methylation in Esophageal Squamous Cell Carcinoma: Biological and Clinical Implications.
Lin L; Cheng X; Yin D
Front Oncol; 2020; 10():549850. PubMed ID: 33194605
[TBL] [Abstract][Full Text] [Related]
15. The Long Pentraxin PTX3 as a Link Between Innate Immunity, Tissue Remodeling, and Cancer.
Doni A; Stravalaci M; Inforzato A; Magrini E; Mantovani A; Garlanda C; Bottazzi B
Front Immunol; 2019; 10():712. PubMed ID: 31019517
[TBL] [Abstract][Full Text] [Related]
16. Pentraxin 3 overexpression accelerated tumor metastasis and indicated poor prognosis in hepatocellular carcinoma via driving epithelial-mesenchymal transition.
Song T; Wang C; Guo C; Liu Q; Zheng X
J Cancer; 2018; 9(15):2650-2658. PubMed ID: 30087705
[TBL] [Abstract][Full Text] [Related]
17. PTX3, a Humoral Pattern Recognition Molecule, in Innate Immunity, Tissue Repair, and Cancer.
Garlanda C; Bottazzi B; Magrini E; Inforzato A; Mantovani A
Physiol Rev; 2018 Apr; 98(2):623-639. PubMed ID: 29412047
[TBL] [Abstract][Full Text] [Related]
18. Pentraxin-3 is a PI3K signaling target that promotes stem cell-like traits in basal-like breast cancers.
Thomas C; Henry W; Cuiffo BG; Collmann AY; Marangoni E; Benhamo V; Bhasin MK; Fan C; Fuhrmann L; Baldwin AS; Perou C; Vincent-Salomon A; Toker A; Karnoub AE
Sci Signal; 2017 Feb; 10(467):. PubMed ID: 28223411
[TBL] [Abstract][Full Text] [Related]
19. Innate immunity, hemostasis and matrix remodeling: PTX3 as a link.
Doni A; Garlanda C; Mantovani A
Semin Immunol; 2016 Dec; 28(6):570-577. PubMed ID: 27881292
[TBL] [Abstract][Full Text] [Related]
20. Pentraxins in the activation and regulation of innate immunity.
Daigo K; Inforzato A; Barajon I; Garlanda C; Bottazzi B; Meri S; Mantovani A
Immunol Rev; 2016 Nov; 274(1):202-217. PubMed ID: 27782337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
